Gene · 2798
Papers2,995
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,995
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and phenotypic differences between sexes in congenital hypogonadotropic hypogonadism (CHH): Large cohort analysis from a single tertiary centre. | Front Endocrinol (Lausanne) | 2022 | 36531499 | PubTator, text mining | PubMed |
| Association Between Diabetes and Immunoglobulin M Antibodies Against Endogenous Gonadotropin-Releasing Hormone in Serum: A Meta-Analysis. | Cureus | 2022 | 36523699 | PubTator, text mining | PubMed |
| Prediction of BRAF V600E variant from cancer gene expression data. | Transl Cancer Res | 2022 | 36523293 | PubTator, text mining | PubMed |
| Testis- specific Y-encoded- like protein 1 and cholesterol metabolism: Regulation of CYP1B1 expression through Wnt signaling. | Front Pharmacol | 2022 | 36518674 | PubTator, text mining | PubMed |
| Erratum to a partial loss-of-function variant in GNRNR gene in a Chinese cohort with idiopathic hypogonadotropic hypogonadism. | Transl Androl Urol | 2022 | 36507481 | PubTator, text mining | PubMed |
| Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women. | Front Pharmacol | 2022 | 36506562 | PubTator, text mining | PubMed |
| Reproductive Performance of Zi-Goose Promoted by Red Color Illumination. | Front Vet Sci | 2022 | 36504854 | PubTator, text mining | PubMed |
| Cancer Stemness/Epithelial-Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target. | Int J Mol Sci | 2022 | 36499245 | PubTator, text mining | PubMed |
| The Therapeutic Landscape of Salivary Gland Malignancies-Where Are We Now? | Int J Mol Sci | 2022 | 36499216 | PubTator, text mining | PubMed |
| "Short agonist stop" protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study. | Front Endocrinol (Lausanne) | 2022 | 36465628 | PubTator, text mining | PubMed |
| Apparent Homozygosity for a gr/gr AZFc Deletion in A 47,XYY Man with Oligozoospermia and Secondary Infertility. | J Reprod Infertil | 2022 | 36452190 | PubTator, text mining | PubMed |
| The Recent Development of Multifunctional Gold Nanoclusters in Tumor Theranostic and Combination Therapy. | Pharmaceutics | 2022 | 36432642 | PubTator, text mining | PubMed |
| Development and Validation of an LC-MS/MS Method for Simultaneous Determination of Short Peptide-Based Drugs in Human Blood Plasma. | Molecules | 2022 | 36431933 | PubTator, text mining | PubMed |
| Biochemical Targets and Molecular Mechanism of Ginsenoside Compound K in Treating Osteoporosis Based on Network Pharmacology. | Int J Mol Sci | 2022 | 36430397 | PubTator, text mining | PubMed |
| Plant-based expression platforms to produce high-value metabolites and proteins. | Front Plant Sci | 2022 | 36426139 | PubTator, text mining | PubMed |
| Reversible hypogonadotropic hypogonadism in men with the fertile eunuch/Pasqualini syndrome: A single-center natural history study. | Front Endocrinol (Lausanne) | 2022 | 36407308 | PubTator, text mining | PubMed |
| Correlation between Hashimoto's thyroiditis and polycystic ovary syndrome: A systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2022 | 36387911 | PubTator, text mining | PubMed |
| Impulsive time series modeling with application to luteinizing hormone data. | Front Endocrinol (Lausanne) | 2022 | 36387902 | PubTator, text mining | PubMed |
| GNRHR-related central hypogonadism with spontaneous recovery - case report. | Ital J Pediatr | 2022 | 36371229 | PubTator, text mining | PubMed |
| Peptide-Drug Conjugates: A New Hope for Cancer Management. | Molecules | 2022 | 36364057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2798/papers?page=18